Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library

[1]  P. Lantos,et al.  Chronic Lyme disease. , 2015, Infectious disease clinics of North America.

[2]  P. Krause,et al.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  G. Wormser,et al.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Barthold,et al.  Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice , 2014, PloS one.

[5]  Ying Zhang.  Persisters, persistent infections and the Yin–Yang model , 2014, Emerging Microbes & Infections.

[6]  J. Halperin,et al.  Treatment trials for post-Lyme disease symptoms revisited. , 2013, The American journal of medicine.

[7]  S. Chiantia,et al.  Proving Lipid Rafts Exist: Membrane Domains in the Prokaryote Borrelia burgdorferi Have the Same Properties as Eukaryotic Lipid Rafts , 2013, PLoS pathogens.

[8]  E. Shapiro,et al.  Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design. , 2012, Vector borne and zoonotic diseases.

[9]  L. Bockenstedt,et al.  Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. , 2012, The Journal of clinical investigation.

[10]  J. Pogliano,et al.  Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins , 2012, Journal of bacteriology.

[11]  M. Barer,et al.  Targeting Persisters for Tuberculosis Control , 2012, Antimicrobial Agents and Chemotherapy.

[12]  H. Steel,et al.  Clofazimine: current status and future prospects. , 2012, The Journal of antimicrobial chemotherapy.

[13]  S. Narasimhan,et al.  Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection , 2012, PloS one.

[14]  J. Radolf,et al.  Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes , 2012, Nature Reviews Microbiology.

[15]  J. Halperin.  Lyme disease: an evidence-based approach. , 2011 .

[16]  D. Norris,et al.  Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. , 2010, Ticks and tick-borne diseases.

[17]  B. Luft,et al.  Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi , 2009, Antimicrobial Agents and Chemotherapy.

[18]  L. Margulis,et al.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic Tigecycline , 2009, Proceedings of the National Academy of Sciences.

[19]  G. Wormser,et al.  Antibiotic Treatment of Animals Infected with Borrelia burgdorferi , 2009, Clinical Microbiology Reviews.

[20]  J. Czub,et al.  Amphotericin B and its new derivatives - mode of action. , 2009, Current drug metabolism.

[21]  S. Barthold,et al.  Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice , 2008, Antimicrobial Agents and Chemotherapy.

[22]  K. Hunfeld,et al.  Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don't know, and what we need to know , 2006, Wiener klinische Wochenschrift.

[23]  J. Halperin,et al.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Jun O. Liu,et al.  A clinical drug library screen identifies astemizole as an antimalarial agent , 2006, Nature chemical biology.

[25]  R. Nadelman,et al.  Long-term follow-up of patients with culture-confirmed Lyme disease. , 2003, The American journal of medicine.

[26]  T. Hartung,et al.  Borrelia burgdorferi-Induced Tolerance as a Model of Persistence via Immunosuppression , 2003, Infection and Immunity.

[27]  L. Hyman,et al.  Study and treatment of post Lyme disease (STOP-LD) , 2003, Neurology.

[28]  S. Brorson,et al.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[29]  R. Straubinger,et al.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment , 1997, Journal of clinical microbiology.

[30]  K. Failing,et al.  In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values. , 1995, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[31]  E. Aberer,et al.  Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi , 1995, Antimicrobial agents and chemotherapy.

[32]  J. Arbiser,et al.  Clofazimine: a review of its medical uses and mechanisms of action. , 1995, Journal of the American Academy of Dermatology.

[33]  A. Barbour,et al.  In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies , 1992, Journal of clinical microbiology.

[34]  Seema Patel,et al.  Evaluation of In-vitro Antibiotic Susceptibility of Different Morphological Forms of Borrelia burgdorferi , 2015 .

[35]  J. Miklossy,et al.  Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis , 2008, Journal of Neuroinflammation.

[36]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[37]  H. Sackeim,et al.  Ahead of Print on October 10 , 2007 ( Neurology . 2007 Oct 10 ) , 2007 .

[38]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.